| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00428-007-0535-Z |
| P698 | PubMed publication ID | 18000680 |
| P50 | author | Alberto Gallardo | Q41112914 |
| P2093 | author name string | Belen Lloveras | |
| Enrique Lerma | |||
| Josefina Muñoz | |||
| Jaime Prat | |||
| Lluis Catasus | |||
| Cristina Pons | |||
| Josefina Fuentes | |||
| Marisa Romero | |||
| P2860 | cites work | Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer | Q73783297 |
| Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma | Q73798162 | ||
| Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder | Q77973125 | ||
| Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians | Q77978469 | ||
| Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis | Q78582557 | ||
| A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression | Q79150068 | ||
| Immune responses to human papillomavirus in genital tract of women with cervical cancer | Q81299133 | ||
| ??? | Q57270107 | ||
| CD95's deadly mission in the immune system | Q28142072 | ||
| Assignment of the human Fas antigen gene (Fas) to 10q24.1 | Q28188700 | ||
| Epidemiologic classification of human papillomavirus types associated with cervical cancer | Q29616213 | ||
| HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity | Q34339800 | ||
| The human papillomavirus E6 protein and its contribution to malignant progression | Q34468780 | ||
| Estimating the world cancer burden: Globocan 2000. | Q34518922 | ||
| The CD95(APO-1/Fas) DISC and beyond | Q35091401 | ||
| Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection | Q36641617 | ||
| Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR. | Q36641753 | ||
| T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis | Q37527634 | ||
| Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis | Q40422356 | ||
| Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin | Q40974954 | ||
| Interactions of the human papillomavirus E7 protein with cell cycle regulators | Q41585234 | ||
| Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement | Q41893919 | ||
| Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma | Q42467025 | ||
| Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study | Q42474547 | ||
| Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production | Q43824472 | ||
| Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction | Q43964697 | ||
| Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection | Q46215592 | ||
| Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma | Q47230945 | ||
| Cancer in twins: genetic and nongenetic familial risk factors. | Q50971456 | ||
| Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. | Q53342350 | ||
| Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction. | Q53356618 | ||
| Evaluation of Fas gene promoter polymorphism in cervical cancer patients. | Q53366183 | ||
| No evidence of the involvement of the Fas -670 promoter polymorphism in cervical cancer in situ. | Q54705343 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| Cervical cancer | Q56091932 | ||
| Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer | Q59219447 | ||
| Identification and characterisation of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene | Q61863688 | ||
| Polymorphism in codons 10 and 25 of the transforming growth factor-beta 1 (TGF-beta1) gene in patients with invasive squamous cell carcinoma of the uterine cervix | Q62488763 | ||
| Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege | Q63408406 | ||
| Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes | Q71644411 | ||
| HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18 | Q71669164 | ||
| Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes | Q71699517 | ||
| The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer | Q71803276 | ||
| Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? | Q71840957 | ||
| Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance | Q72996726 | ||
| P433 | issue | 1 | |
| P921 | main subject | cervical squamous cell carcinoma | Q18556057 |
| P304 | page(s) | 65-74 | |
| P577 | publication date | 2007-11-14 | |
| P1433 | published in | Virchows Archiv | Q19059548 |
| P1476 | title | Prognostic significance of the Fas-receptor/Fas-ligand system in cervical squamous cell carcinoma | |
| P478 | volume | 452 |
| Q35893369 | A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival |
| Q37565239 | FAS-670 gene polymorphism and cervical carcinogenesis risk: A meta-analysis |
| Q37736549 | FasL gene -844T/C mutation of esophageal cancer in South China and its clinical significance |
| Q37953721 | Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review |
| Q38560697 | Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes |
| Q34833111 | Lack of association between Fas rs180082 polymorphism and risk of cervical cancer: an update by meta-analysis |
| Q26995847 | The role of CD95 and CD95 ligand in cancer |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.